Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nu Skin Enterprises, Inc. Common Stock (NY: NUS )

7.830 +0.560 (+7.70%)
Streaming Delayed Price Updated: 3:01 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nu Skin Enterprises, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Looking Into Nu Skin Enterprises's Return On Capital Employed
Nu Skin Enterprises (NYSE:NUS) brought in sales totaling $673.44 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 118.56%, resulting in a loss of $9.23... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
Cowen & Co. raised Yum! Brands, Inc. (NYSE: YUM) price target from $134 to $143. Yum! Brands shares fell 0.3% to $123.00 in pre-market trading. Keybanc cut the price target... 
Via Benzinga
Recap: Nu Skin Enterprises Q4 Earnings
  Nu Skin Enterprises (NYSE:NUS) reported its Q4 earnings results on Wednesday, February 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Nu Skin Enterprises Inc Class A (NUS) Q3 2021 Earnings Call Transcript
NUS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
5 Value Stocks To Watch In The Consumer Defensive Sector
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Goldman Sachs lowered the price target on Nucor Corporation (NYSE: 
Via Benzinga
Nu Skin Cuts Q3 Revenue Outlook As Delta Variant Disrupts Sales
Nu Skin Enterprises Inc (NYSE: NUS) expects third-quarter revenue of $637 million -$642 million (consensus $710.11 million), down from the previous guidance of $... 
Via Benzinga
3 Cheap Healthcare Stocks to Buy Right Now
The COVID-19 pandemic brought a renewed interest into the healthcare sector, and with the surging Delta variant raging across the country, that interest isn’t expected to dissipate anytime soon. 
Via Talk Markets
Exposures COVID-19
7 Low Price-To-Sales Stocks To Buy In The Current Market
A stock’s price-to-sales ratio reflects how much investors are paying for each dollar of revenue generated by a company. 
Via Talk Markets
Value Stocks & ETFs to Buy Now
Value stocks had been out of favor for many years, but the trend reversed late last year in anticipation of a powerful economic rebound. 
Via Talk Markets
Nu Skin Enterprises Inc Class A (NUS) Q2 2021 Earnings Call Transcript
NUS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Price To Earnings Ratio Insights For Nu Skin Enterprises
Right now, Nu Skin Enterprises Inc. (NYSE:NUS) share price is at $53.83, after a 0.25% gain. Moreover, over the past month, the stock fell by 4.36%, but in the past... 
Via Benzinga
Nu Skin Subsidiary Signs Agreement With Superior Farms
Nu Skin Enterprises Inc (NYSE: NUS) subsidiary Grōv Technologies has signed an agreement with California-based Superior Farms for 10 Olympus Tower Farms to produce fresh year-... 
Via Benzinga
Nu Skin Shines After 3 Quarters Double- And Triple-Digit Profit, Sales Growth
A Relative Strength Rating upgrade for Nu Skin Enterprises Inc shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Estee Lauder Earns Relative Strength Rating Upgrade Amid Rising Sales, Profits Including 87% Pop In EPS In Q1
Estee Lauder shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
Nu Skin Enterprises Sees A Welcome RS Rating Increase
A Relative Strength Rating upgrade for Nu Skin Enterprises Inc shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Medifast, In A Buy Zone, Shows Rising RS Rating
Nutrition and weight loss company Medifast is showing improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
Mid-Afternoon Market Update: Dow Jumps 100 Points; Fastly Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.31% to 34,337.14 while the NASDAQ fell 0.61% to 13,498.90. The S&P also rose, gaining 0.07% to 4,170.56. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Nu Skin Enterprises Inc (NUS) Q1 2021 Earnings Call Transcript
NUS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Honest Company IPO Sees High Demand After String Of Setbacks
The Honest Company IPO was "well oversubscribed" ahead of an anticipated pricing on Tuesday and debut for Wednesday, according to IPO Boutique. 
Via Investor's Business Daily
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.